Editing Polycystic ovary syndrome (section)

== Definition ==
Two definitions are commonly used:
; '''NIH'''
: In 1990, a consensus workshop sponsored by the [[NIH]]/[[NICHD]] suggested that a person has PCOS if they have all of the following:<ref name=emedicine_main>{{EMedicine|article|256806|Polycystic Ovarian Syndrome}}</ref>{{pb}}{{numbered list|[[Oligoovulation]]|Signs of [[androgen excess]] (clinical or biochemical)|Exclusion of other disorders that can result in menstrual irregularity and hyperandrogenism (e.g.: Congenital Suprarrenal Hyperplasia, androgen producer tumors, hyperprolactinemia).}}
; '''Rotterdam'''
: In 2003, a consensus workshop sponsored by [[ESHRE]]/[[ASRM]] in [[Rotterdam]] indicated PCOS to be present if any two out of three criteria are met, in the absence of other entities that might cause these findings:<ref name=BMC2010 /><ref name="Azziz-2006">{{cite journal | vauthors = Azziz R | title = Controversy in clinical endocrinology: diagnosis of polycystic ovarian syndrome: the Rotterdam criteria are premature | journal = The Journal of Clinical Endocrinology and Metabolism | volume = 91 | issue = 3 | pages = 781–5 | date = March 2006 | pmid = 16418211 | doi = 10.1210/jc.2005-2153 | doi-access = free }}</ref><ref name=HumRep_Rotterdam>{{cite journal | title = Revised 2003 consensus on diagnostic criteria and long-term health risks related to polycystic ovary syndrome (PCOS) | journal = Human Reproduction | volume = 19 | issue = 1 | pages = 41–47 | date = January 2004 | pmid = 14688154 | doi = 10.1093/humrep/deh098 | doi-access = free | author1 = Rotterdam ESHRE/ASRM-Sponsored PCOS consensus workshop group }}</ref>{{pb}}{{numbered list|[[Oligoovulation]] and/or [[anovulation]]|Excess androgen activity|Polycystic ovaries (by [[gynecologic ultrasound]])}}{{pb}}The Rotterdam definition is wider, including many more women, the most notable ones being women without androgen excess. Critics say that findings obtained from the study of women with androgen excess cannot necessarily be extrapolated to women without androgen excess.<ref>{{cite journal | vauthors = Carmina E | title = Diagnosis of polycystic ovary syndrome: from NIH criteria to ESHRE-ASRM guidelines | journal = Minerva Ginecologica | volume = 56 | issue = 1 | pages = 1–6 | date = February 2004 | pmid = 14973405 | url = https://www.minervamedica.it/en/journals/minerva-obstetrics-gynecology/article.php?cod=R09Y2004N01A0001 | id = {{NAID|10025610607}} | access-date = 13 October 2021 | archive-date = 2 November 2021 | archive-url = https://web.archive.org/web/20211102082824/https://www.minervamedica.it/en/journals/minerva-obstetrics-gynecology/article.php?cod=R09Y2004N01A0001 | url-status = live }}</ref><ref>{{cite journal | vauthors = Hart R, Hickey M, Franks S | title = Definitions, prevalence and symptoms of polycystic ovaries and polycystic ovary syndrome | journal = Best Practice & Research. Clinical Obstetrics & Gynaecology | volume = 18 | issue = 5 | pages = 671–683 | date = October 2004 | pmid = 15380140 | doi = 10.1016/j.bpobgyn.2004.05.001 }}</ref>
; '''Androgen Excess PCOS Society'''
: In 2006, the Androgen Excess PCOS Society suggested a tightening of the diagnostic criteria to all of the following:<ref name=BMC2010 />{{pb}}{{numbered list|Excess [[androgen]] activity|Oligoovulation/anovulation and/or polycystic ovaries|Exclusion of other entities that would cause excess androgen activity}}